F8 / Coagulation factor VIII · Western blot design guide

Design a Western Blot for F8

Real validated F8 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-F8 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for F8: expected band ~267 kDa, hero antibody PA2061, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable F8 Western blot protocol sheet — expected band ~267 kDa, antibody PA2061, controls and PMC citations. Open the full F8 WB guide →

F8 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~267 kDa
Observed band ~92 kDa
Gel 5–20% (catalog PA2061)
Positive control ⓘ Adipose tissue (IHC candidate; verify WB) +4 more
Negative control ⓘ Spleen (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Glycosylated + Cleaved
Caveat Band identity controls
Gene-set association MSigDB Hallmark membership
Isoform 2 isoform(s)
Section 1

Real Curated F8 Western Blot Protocols

The PA2061 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysaterat kidney, rat lung, rat heart (catalog PA2061)
Gel %5–20% (catalog PA2061)
Load50ug; reducing conditions (catalog PA2061)
Transfera Nitrocellulose membrane at 150mA for 50-90 minutes (catalog PA2061)
MembraneNitrocellulose membrane (catalog PA2061)
Blocking5% Non-fat Milk/ TBS for 1.5 hour at RT (catalog PA2061)
Primary antibodyPA2061 · 0.5 μg/mL (catalog PA2061)
Primary incubationovernight at 4°C (catalog PA2061)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:10000 (catalog PA2061)
Secondary incubation1.5 hour at RT (catalog PA2061)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog PA2061)
DetectionECL (catalog PA2061)
Section 2

What Is the Expected F8 Western Blot Band Size?

F8 has a predicted 267 kDa precursor and an empirical ~92 kDa antibody band; the supplied evidence does not establish the cause of their difference.

What am I looking at on my blot?
Band near 92 kDaEmpirical F8 antibody signal; confirm identity with band controls
Band near 267 kDaConsistent with the predicted full-length precursor mass
Band slightly below the precursorCould reflect cleavage of the 1–19 signal peptide
Broad smearHeterogeneous N-linked glycosylation is possible but unproven
Multiple bandsIsoforms 1 and 2 could contribute, but distinct migration is unestablished
Little or no lysate bandF8 is secreted into the extracellular space
💡Expected F8 appearanceUniProt predicts a 267 kDa precursor, while antibody QC reports a ~92 kDa band; the supplied features do not explain that difference, so confirm band identity with independent controls.
How each factor affects band size
Predicted precursor massUniProt predicts 267 kDa for full-length F8
N-linked glycosylation at Asn60May alter apparent migration; the site alone establishes no visible shift
Signal peptide at residues 1–19Cleavage makes mature F8 slightly smaller than its precursor but does not explain the ~92 kDa band
Splice isoforms 1 and 2May differ in size; their masses and migration are not supplied
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateF8 is secretedCheck extracellular or conditioned medium and a positive control
Band higher than expectedN-linked glycosylation may affect migrationCompare matched samples before and after deglycosylation
Band lower than expectedThe ~92 kDa signal is reported, but its difference from 267 kDa is unexplainedConfirm identity with an independent antibody and F8 depletion control
Broad smear instead of sharp bandHeterogeneous N-linked glycosylation is possibleCompare matched samples before and after deglycosylation
Multiple bandsIsoforms 1 and 2 are listed, but distinct bands are unprovenCheck band identity with an independent antibody and F8 depletion control

Sample controls for F8 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for F8 in Western blot, you can use adipose tissue, which HPA scores High.
Positive control: Adipose tissue (IHC candidate; verify WB)
Negative control: Spleen (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: F8 is secreted, so whole-cell lysates may yield little signal; extracellular samples may work better.

HPA tissue expression evidence for F8

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes High Protein (IHC) HPA →
Bronchus ciliated cells (tip of cilia) High Protein (IHC) HPA →
Kidney cells in tubules High Protein (IHC) HPA →
Lung endothelial cells High Protein (IHC) HPA →
Placenta endothelial cells High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Spleen cells in red pulp Not detected Protein (IHC) HPA →
Appendix glandular cells Low Protein (IHC) HPA →
Caudate neuronal cells Low Protein (IHC) HPA →
Cerebellum cells in granular layer Low Protein (IHC) HPA →
Cerebral cortex endothelial cells Low Protein (IHC) HPA →
Section 3

Advanced F8 Western Blot Tips

Deeper troubleshooting and optimisation questions for F8, answered from its protein features.

How should F8 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could isoform 2 account for a shorter band?
Isoforms · Isoform 2 replaces canonical residues 1–8 with MRIQDPGK and lacks residues 9–2143. An isoform-specific assay would be needed to assign a short band to it. These UniProt coordinates use the supplied canonical sequence; do not treat the observed 92 kDa band as isoform 2 on size alone.
Could F8 glycosylation change its apparent migration?
PTM · F8 has 22 annotated N-linked glycosylation sites, including residues 60, 258, 601, 1829, and 2137. Compare the same verified F8 species across samples when assessing migration. Site annotations establish modification locations, but do not establish the size or direction of a visible band shift.
Does this guide establish induction of F8?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for F8?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the PA2061 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should F8 be quantified on a Western blot?
Quantitation · Quantify the same verified F8 band across comparable samples and report which band was measured. F8 is secreted into extracellular space, and vWF binding stabilizes it in circulation, so sample compartment and vWF context matter when comparing abundance. The supplied features do not establish that the 92 kDa band represents total F8.
Why does the observed F8 band differ from the predicted mass?
Interpretation · The predicted mass is 267 kDa, while the reported band is about 92 kDa. F8 has a signal peptide at residues 1–19 and 22 annotated N-linked glycosylation sites, but those features alone cannot identify the 92 kDa species or explain the difference. Verify the band’s F8 identity before assigning it to a particular form.

The annotated sulfotyrosines are at UniProt positions 365, 737, 738, 742, 1683, and 1699. Record these coordinates when comparing constructs or antibody targets, since another numbering convention may differ. Sulfation at these sites does not, by itself, establish a visible band shift.

F8 has eight annotated disulfide bonds. Compare reducing and nonreducing conditions if band migration changes, and identify the detected species before assigning a band. The bond count alone does not establish the identity or mass of an unexpected band.

The annotated signal peptide spans UniProt residues 1–19, and F8 is secreted. Its removal alone cannot account for the difference between the 267 kDa prediction and an observed band near 92 kDa. Confirm the band’s identity before interpreting it as a specific F8 species.
Boster reagents

F8 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of Factor VIII using anti-Factor VIII antibody (PA2061). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 50ug of sample under reducing conditions. Lane 1: rat kidney tissue lysates, Lane 2: rat lung tissue lysates, Lane 3: rat heart tissue lysates, Lane 4: mouse kidney tissue lysates, Lane 5: mouse lung tissue lysates, Lane 6: human Hela whole cell lysates, Lane 7: human HepG2 whole cell lysates, After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-Factor VIII antigen affinity purified polyclonal antibody (Catalog # PA2061) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:10000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for Factor VIII at approximately 92KD. The expected band size for Factor VIII is at 92KD.
Anti-Factor VIII/F8 Antibody Picoband®
Cat # PA2061
Real WB data Western Blot analysis of various cells using Factor VIII Polyclonal Antibody
Anti-Factor VIII F8 Antibody
Cat # A00367

Two anti-F8 antibodies are listed for Western blot: PA2061 (human, mouse, rat) and A00367 (human, mouse). Both have WB images, but only PA2061 has a detailed caption identifying samples, conditions, and an approximately 92 kDa band.

Which to pick: Choose PA2061 for rat samples or when documented WB conditions matter; its image includes rat tissues, mouse tissues, and human cell lysates. A00367 lists human and mouse reactivity, but its WB caption does not identify the cells or band size.

Source: BosterBio F8 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.